Form 4 for TWST Twist Bioscience Corp
Accepted 2021-12-27 00:00:00 ET · period of report 2021-12-22 · accession 0001214659-21-013645 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-27 | 2021-12-22 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $8.82 | +5,994 | 44.2K | +16% | +$52.9K |
| D | 2021-12-27 | 2021-12-22 | TWST | Finn Patrick John | Chief Commercial Off | S - Sale+OE | $85.09 | -5,994 | 38.2K | -14% | -$510.0K |
| D | 2021-12-27 | 2021-12-22 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $0.00 | -5,994 | 9,273 | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | M | A | 5,994 | $8.82 | 44,228 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-22 | S | D | 5,994 | $85.09 | 38,234 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-12-22 | M | D | 5,994 | $0.00 | 9,273 | D | $8.82 · — to 2027-09-28 | 5,994 Common Stock | (F2) The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |